Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)

SHE:300194 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	978.78	846.31	991.84	688.53	981.13	853.39
Trading Asset Securities	30.05	30	5.05	15.21	20.86	75.67
Cash & Short-Term Investments	1,009	876.32	996.89	703.74	1,002	929.05
Cash Growth	1.98%	-12.10%	41.66%	-29.77%	7.85%	7.83%
Accounts Receivable	278.41	255.39	359.39	433.24	393.02	370.1
Other Receivables	11.3	31.31	23.8	18.92	19.66	17.89
Receivables	289.72	286.71	383.19	452.16	412.68	387.98
Inventory	797.86	850.97	707.8	719.75	631.92	590.17
Prepaid Expenses	-	-	-	-	-	0.34
Other Current Assets	65.97	51.7	38.36	51.42	38.6	41.76
Total Current Assets	2,162	2,066	2,126	1,927	2,085	1,949
Property, Plant & Equipment	1,740	1,767	1,736	1,696	1,446	1,222
Long-Term Investments	1,225	1,216	1,183	1,072	752.43	699.42
Goodwill	261.18	261.18	261.18	485.69	508.66	709.72
Other Intangible Assets	438.97	441.2	401.71	383.81	382.37	1,015
Long-Term Deferred Tax Assets	64.43	60.54	65.81	101.86	49.15	40.16
Long-Term Deferred Charges	105.83	105.37	138.52	176.2	170.25	135.89
Other Long-Term Assets	80.78	61.6	63.37	35.35	312.58	201.07
Total Assets	6,079	5,979	5,976	5,878	5,706	5,973
Accounts Payable	379.38	436.39	379.48	385.07	289.77	216.04
Accrued Expenses	13.8	116.73	225.43	253.93	232.76	225.46
Short-Term Debt	440.29	333.32	349.11	406.34	642.15	477.5
Current Portion of Long-Term Debt	38.6	177.32	54.06	2.51	-	-
Current Portion of Leases	-	1.11	0.98	0.58	-	19.91
Current Income Taxes Payable	22.93	4.46	15.52	6.62	9	12.46
Current Unearned Revenue	43.69	54.09	51.25	61.96	57.15	56.21
Other Current Liabilities	136.85	103.58	119.22	170.04	57.66	53.95
Total Current Liabilities	1,076	1,227	1,195	1,287	1,288	1,062
Long-Term Debt	398.97	193.54	487.14	303.7	263.88	124.21
Long-Term Leases	0.69	0.49	1.57	1.06	-	-
Long-Term Unearned Revenue	107.24	109.91	92.36	98.06	75.03	53.09
Long-Term Deferred Tax Liabilities	49.38	49.5	51.09	64.35	35.92	31.64
Other Long-Term Liabilities	0.01	0.01	0.01	177.27	177.27	147.25
Total Liabilities	1,632	1,580	1,827	1,932	1,841	1,418
Common Stock	1,190	1,190	1,190	1,190	1,190	1,190
Additional Paid-In Capital	2,237	2,237	2,237	2,227	2,227	2,231
Retained Earnings	1,021	952.26	731.91	559.53	354.92	711.32
Comprehensive Income & Other	-2.68	16.74	-13.98	-31.58	-37.96	-31.74
Total Common Equity	4,446	4,396	4,145	3,945	3,734	4,100
Minority Interest	2	2.25	3.92	1.38	131.75	454.87
Shareholders' Equity	4,448	4,398	4,149	3,946	3,866	4,555
Total Liabilities & Equity	6,079	5,979	5,976	5,878	5,706	5,973
Total Debt	878.56	705.78	892.86	714.2	906.03	621.62
Net Cash (Debt)	130.28	170.54	104.03	-10.45	95.96	307.43
Net Cash Growth	-41.95%	63.93%	-	-	-68.79%	-58.79%
Net Cash Per Share	0.11	0.15	0.09	-0.01	0.08	0.26
Filing Date Shares Outstanding	1,190	1,190	1,190	1,190	1,190	1,190
Total Common Shares Outstanding	1,190	1,190	1,190	1,190	1,190	1,190
Working Capital	1,087	838.7	931.19	640.01	796.7	887.77
Book Value Per Share	3.74	3.69	3.48	3.32	3.14	3.45
Tangible Book Value	3,745	3,693	3,482	3,076	2,843	2,376
Tangible Book Value Per Share	3.15	3.10	2.93	2.59	2.39	2.00
Buildings	-	1,246	1,191	875.88	871.16	724.77
Machinery	-	1,765	1,615	1,347	1,225	1,072
Construction In Progress	-	114.23	155.84	695.25	441.2	427.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.